Replies to post #340748 on Innovation Pharmaceuticals Inc (IPIX)

[rmzport]

"enrolling approximately 120 hospitalized patients with moderate-to-severe COVID-19, to further evaluate Brilacidin’s COVID-19 treatment potential."

[To infinity and beyond!]

OK I read it. No start announced. Recall that Leo has been talking about this trial since April 6 2020 and said for sure q4 start many times. Many here said this q4 start was guaranteed.

Oh well. it's biotech, right?

Why should we believe January start?

The pace of research over the summer and the failure to move forward quickly has been horrendous. Leo lost all momentum.

A big pharma partner woulda meant otherwise, but it never materialized.

If B succeeds in the trial it will be a miracle and all here will have shares worth 10-100x today. It is asking a lot.

[loanranger]

"Just read the last paragraph of today's update to get the answer to your question"

Has the lack of any reference to timing rendered you skeptical?
"The Company will be initiating a Phase 2, randomized, placebo-controlled clinical trial, enrolling approximately 120 hospitalized patients with moderate-to-severe COVID-19, to further evaluate Brilacidin’s COVID-19 treatment potential."


This is only 6 days old:
“Fast Track designation is well-timed as we anticipate starting our Phase 2 clinical trial in hospitalized COVID-19 patients this month, and should help bring Brilacidin to patients faster in these dire times.”
Do you think it no longer applies?